NR3C1 and Sepsis: Our hypothesis is that specifically stimulating hepatic (as opposed to systemic) GR activity in AH patients with dysregulated expression of chemokines and APPs may be more beneficial in treating AH and preventing/treating sepsis in part by restoring a more appropriate chemokine balance and inducing APPs.